Clearline Capital’s Integra LifeSciences IART Stock Holding History

Clearline Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$773K	Hold	43,014	–	–	0.05%	95
2026 Q1	$405K	Hold	43,014	–	–	0.02%	104
2025 Q4	$534K	Buy	43,014 +200	+0.5%	+$2.66K	0.03%	97
2025 Q3	$614K	Hold	42,814	–	–	0.03%	100
2025 Q2	$525K	Hold	42,814	–	–	0.02%	102
2025 Q1	$941K	Hold	42,814	–	–	0.06%	92
2024 Q4	$971K	Sell	42,814 -187,583	-81%	-$4.09M	0.13%	82
2024 Q3	$4.19M	Buy	230,397 +159,903	+227%	+$3.71M	0.18%	76
2024 Q2	$2.05M	Sell	70,494 -130,557	-65%	-$3.87M	0.06%	92
2024 Q1	$7.13M	Hold	201,051	–	–	0.35%	45
2023 Q4	$8.76M	Buy	201,051 +22,861	+13%	+$900K	0.54%	36
2023 Q3	$6.81M	Sell	178,190 -65,545	-27%	-$2.76M	0.58%	47
2023 Q2	$10M	Buy	+243,735	New	+$11.7M	0.58%	26

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Clearline Capital's IART Position: Q2 2026 in Review

Clearline Capital held its Integra LifeSciences (IART) position steady in Q2 2026 at 43,014 shares worth $773K. The position accounts for 0.05% of the portfolio, ranked #95.

Clearline Capital first reported a position in IART in Q2 2023 and has held it in 13 quarters since. The position peaked at $10M in Q2 2023. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Clearline Capital held 43,014 shares of Integra LifeSciences worth $773K as of Q2 2026.
Clearline Capital left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up 0.05% of Clearline Capital's portfolio in Q2 2026, its #95 holding.
Clearline Capital first reported a position in Integra LifeSciences in Q2 2023 and has held it in 13 quarters since.
Clearline Capital's Integra LifeSciences position peaked at $10M in Q2 2023.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.